• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

改善帕金森病风险评估——增强型PREDICT-PD算法

Improving estimation of Parkinson's disease risk-the enhanced PREDICT-PD algorithm.

作者信息

Bestwick Jonathan P, Auger Stephen D, Simonet Cristina, Rees Richard N, Rack Daniel, Jitlal Mark, Giovannoni Gavin, Lees Andrew J, Cuzick Jack, Schrag Anette E, Noyce Alastair J

机构信息

Preventive Neurology Unit, Wolfson Institute of Preventive Medicine, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London, UK.

Department of Clinical and Movement Neuroscience, UCL Institute of Neurology, University College London, London, UK.

出版信息

NPJ Parkinsons Dis. 2021 Apr 1;7(1):33. doi: 10.1038/s41531-021-00176-9.

DOI:10.1038/s41531-021-00176-9
PMID:33795693
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8017005/
Abstract

We previously reported a basic algorithm to identify the risk of Parkinson's disease (PD) using published data on risk factors and prodromal features. Using this algorithm, the PREDICT-PD study identified individuals at increased risk of PD and used tapping speed, hyposmia and REM sleep behaviour disorder (RBD) as "intermediate" markers of prodromal PD in the absence of sufficient incident cases. We have now developed and tested an enhanced algorithm which incorporates the intermediate markers into the risk model. Risk estimates were compared using the enhanced and the basic algorithm in members of the PREDICT-PD pilot cohort. The enhanced PREDICT-PD algorithm yielded a much greater range of risk estimates than the basic algorithm (93-609-fold difference between the 10th and 90th centiles vs 10-13-fold respectively). There was a greater increase in the risk of PD with increasing risk scores for the enhanced algorithm than for the basic algorithm (hazard ratios per one standard deviation increase in log risk of 2.75 [95% CI 1.68-4.50; p < 0.001] versus 1.47 [95% CI 0.86-2.51; p = 0.16] respectively). Estimates from the enhanced algorithm also correlated more closely with subclinical striatal DaT-SPECT dopamine depletion (R = 0.164, p = 0.005 vs R = 0.043, p = 0.17). Incorporating the previous intermediate markers of prodromal PD and using likelihood ratios improved the accuracy of the PREDICT-PD prediction algorithm.

摘要

我们之前报告了一种利用已发表的风险因素和前驱特征数据来识别帕金森病(PD)风险的基本算法。使用该算法,PREDICT-PD研究识别出了患PD风险增加的个体,并在缺乏足够的新发病例时,将敲击速度、嗅觉减退和快速眼动睡眠行为障碍(RBD)用作前驱PD的“中间”标志物。我们现在开发并测试了一种增强算法,该算法将这些中间标志物纳入了风险模型。在PREDICT-PD试点队列的成员中,使用增强算法和基本算法对风险估计值进行了比较。与基本算法相比,增强后的PREDICT-PD算法产生的风险估计值范围要大得多(第10百分位数和第90百分位数之间的差异分别为93 - 609倍和10 - 13倍)。与基本算法相比,增强算法中随着风险评分增加,PD风险的增加幅度更大(对数风险每增加一个标准差的风险比分别为2.75 [95%置信区间1.68 - 4.50;p < 0.001] 和1.47 [95%置信区间0.86 - 2.51;p = 0.16])。增强算法的估计值也与亚临床纹状体DaT-SPECT多巴胺耗竭的相关性更强(R = 0.164,p = 0.005,而R = 0.043,p = 0.17)。纳入先前前驱PD的中间标志物并使用似然比提高了PREDICT-PD预测算法的准确性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/861f/8017005/9534a7fec325/41531_2021_176_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/861f/8017005/4f7d0a37ac87/41531_2021_176_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/861f/8017005/9534a7fec325/41531_2021_176_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/861f/8017005/4f7d0a37ac87/41531_2021_176_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/861f/8017005/9534a7fec325/41531_2021_176_Fig2_HTML.jpg

相似文献

1
Improving estimation of Parkinson's disease risk-the enhanced PREDICT-PD algorithm.改善帕金森病风险评估——增强型PREDICT-PD算法
NPJ Parkinsons Dis. 2021 Apr 1;7(1):33. doi: 10.1038/s41531-021-00176-9.
2
Comparison of different risk scores for Parkinson disease in a population-based 10-year study.基于人群的 10 年研究比较不同帕金森病风险评分。
Eur J Neurol. 2023 Oct;30(10):3347-3352. doi: 10.1111/ene.15971. Epub 2023 Jul 16.
3
PREDICT-PD: An online approach to prospectively identify risk indicators of Parkinson's disease.PREDICT-PD:一种前瞻性识别帕金森病风险指标的在线方法。
Mov Disord. 2017 Feb;32(2):219-226. doi: 10.1002/mds.26898. Epub 2017 Jan 16.
4
Dermal phospho-alpha-synuclein deposits confirm REM sleep behaviour disorder as prodromal Parkinson's disease.皮肤磷酸化α-突触核蛋白沉积证实快速眼动睡眠行为障碍为帕金森病前驱症状。
Acta Neuropathol. 2017 Apr;133(4):535-545. doi: 10.1007/s00401-017-1684-z. Epub 2017 Feb 8.
5
Prodromal features for Parkinson's disease--baseline data from the TREND study.帕金森病的前驱特征——TREND研究的基线数据。
Eur J Neurol. 2014 May;21(5):766-72. doi: 10.1111/ene.12382. Epub 2014 Feb 24.
6
Validation of the MDS research criteria for prodromal Parkinson's disease: Longitudinal assessment in a REM sleep behavior disorder (RBD) cohort.验证前驱期帕金森病的 MDS 研究标准:在 REM 睡眠行为障碍 (RBD) 队列中的纵向评估。
Mov Disord. 2017 Jun;32(6):865-873. doi: 10.1002/mds.26989. Epub 2017 Apr 21.
7
α-Synuclein BAC transgenic mice exhibit RBD-like behaviour and hyposmia: a prodromal Parkinson's disease model.α-突触核蛋白 BAC 转基因小鼠表现出类似 RBD 的行为和嗅觉减退:一种前驱性帕金森病模型。
Brain. 2020 Jan 1;143(1):249-265. doi: 10.1093/brain/awz380.
8
Clinical and dopamine transporter imaging characteristics of non-manifest LRRK2 and GBA mutation carriers in the Parkinson's Progression Markers Initiative (PPMI): a cross-sectional study.帕金森进展标志物倡议(PPMI)中无明显 LRRK2 和 GBA 突变携带者的临床和多巴胺转运体成像特征:一项横断面研究。
Lancet Neurol. 2020 Jan;19(1):71-80. doi: 10.1016/S1474-4422(19)30319-9. Epub 2019 Oct 31.
9
Increased muscle activity during rapid eye movement sleep correlates with decrease of striatal presynaptic dopamine transporters. IPT and IBZM SPECT imaging in subclinical and clinically manifest idiopathic REM sleep behavior disorder, Parkinson's disease, and controls.快速眼动睡眠期间肌肉活动增加与纹状体突触前多巴胺转运体减少相关。亚临床和临床显性特发性快速眼动睡眠行为障碍、帕金森病及对照组的碘普胺和碘苄胍单光子发射计算机断层扫描成像。
Sleep. 2003 Aug 1;26(5):507-12. doi: 10.1093/sleep/26.5.507.
10
Application of the movement disorder society prodromal Parkinson's disease research criteria in 2 independent prospective cohorts.运动障碍协会帕金森病前驱期研究标准在2个独立前瞻性队列中的应用。
Mov Disord. 2017 Jul;32(7):1025-1034. doi: 10.1002/mds.27035. Epub 2017 May 16.

引用本文的文献

1
Nicotine Therapy for Parkinson's Disease: A Meta-Analysis of Randomized Controlled Trials.帕金森病的尼古丁疗法:随机对照试验的荟萃分析
Biomedicines. 2025 Jul 24;13(8):1814. doi: 10.3390/biomedicines13081814.
2
Substantia Nigra Hyperechogenicity Predicts Parkinson's Disease Risk in Patients With Essential Tremor and Undetermined Tremor: Dual-Cohort Longitudinal Evidence With 8-Year Follow-Up and Bayesian Validation.黑质高回声可预测特发性震颤和震颤待查患者的帕金森病风险:8年随访的双队列纵向证据及贝叶斯验证
Eur J Neurol. 2025 Aug;32(8):e70326. doi: 10.1111/ene.70326.
3
Large-scale plasma proteomics uncovers preclinical molecular signatures of Parkinson's disease and overlap with other neurodegenerative disorders.

本文引用的文献

1
Update of the MDS research criteria for prodromal Parkinson's disease.前驱帕金森病 MDS 研究标准的更新。
Mov Disord. 2019 Oct;34(10):1464-1470. doi: 10.1002/mds.27802. Epub 2019 Aug 14.
2
The Parkinson's phenome-traits associated with Parkinson's disease in a broadly phenotyped cohort.在一个广泛表型队列中与帕金森病相关的帕金森病表型特征。
NPJ Parkinsons Dis. 2019 Mar 27;5:4. doi: 10.1038/s41531-019-0077-5. eCollection 2019.
3
Performance of the Movement Disorders Society criteria for prodromal Parkinson's disease: A population-based 10-year study.
大规模血浆蛋白质组学揭示帕金森病的临床前分子特征及其与其他神经退行性疾病的重叠情况。
medRxiv. 2025 Jul 30:2025.07.30.25332433. doi: 10.1101/2025.07.30.25332433.
4
Wearables-derived risk score for unintrusive detection of α-synuclein aggregation or dopaminergic deficit.用于非侵入性检测α-突触核蛋白聚集或多巴胺能缺陷的可穿戴设备衍生风险评分。
EBioMedicine. 2025 Jul;117:105782. doi: 10.1016/j.ebiom.2025.105782. Epub 2025 Jun 6.
5
Development of a simplified smell test to identify Parkinson's disease using multiple cohorts, machine learning and item response theory.利用多个队列、机器学习和项目反应理论开发一种简化嗅觉测试以识别帕金森病。
NPJ Parkinsons Dis. 2025 Apr 23;11(1):85. doi: 10.1038/s41531-025-00904-5.
6
Self-Reported Motor and Nonmotor Symptoms, Prodromal Parkinson's Disease Probability, and Incident Parkinson's Disease in US Farmers.美国农民自我报告的运动和非运动症状、前驱帕金森病概率及帕金森病发病率
Mov Disord. 2025 May;40(5):855-868. doi: 10.1002/mds.30149. Epub 2025 Feb 14.
7
Ethical Considerations for Identifying Individuals in the Prodromal/Early Phase of Parkinson's Disease: A Narrative Review.识别帕金森病前驱期/早期个体的伦理考虑:叙事综述。
J Parkinsons Dis. 2024;14(s2):S307-S319. doi: 10.3233/JPD-230428.
8
A retrospective study of the MDS criteria for prodromal Parkinson's disease in the general population.对普通人群中前驱期帕金森病的MDS标准的回顾性研究。
NPJ Parkinsons Dis. 2024 Jun 26;10(1):125. doi: 10.1038/s41531-024-00739-6.
9
Genetic analysis and natural history of Parkinson's disease due to the LRRK2 G2019S variant.LRRK2 G2019S 变异所致帕金森病的遗传分析和自然病史。
Brain. 2024 Jun 3;147(6):1996-2008. doi: 10.1093/brain/awae073.
10
Evaluation of the PREDIGT score's performance in identifying newly diagnosed Parkinson's patients without motor examination.在不进行运动检查的情况下评估PREDIGT评分在识别新诊断帕金森病患者方面的表现。
NPJ Parkinsons Dis. 2022 Jul 29;8(1):94. doi: 10.1038/s41531-022-00360-5.
运动障碍学会前驱帕金森病标准的表现:一项基于人群的 10 年研究。
Mov Disord. 2018 Mar;33(3):405-413. doi: 10.1002/mds.27281. Epub 2018 Feb 13.
4
Dopamine reuptake transporter-single-photon emission computed tomography and transcranial sonography as imaging markers of prediagnostic Parkinson's disease.多巴胺转运体单光子发射计算机断层扫描和经颅超声作为帕金森病前驱期的影像学标志物。
Mov Disord. 2018 Mar;33(3):478-482. doi: 10.1002/mds.27282. Epub 2018 Jan 30.
5
PREDICT-PD: An online approach to prospectively identify risk indicators of Parkinson's disease.PREDICT-PD:一种前瞻性识别帕金森病风险指标的在线方法。
Mov Disord. 2017 Feb;32(2):219-226. doi: 10.1002/mds.26898. Epub 2017 Jan 16.
6
MDS research criteria for prodromal Parkinson's disease.前驱期帕金森病的MDS研究标准。
Mov Disord. 2015 Oct;30(12):1600-11. doi: 10.1002/mds.26431.
7
Bradykinesia-akinesia incoordination test: validating an online keyboard test of upper limb function.运动迟缓-运动不能不协调测试:验证上肢功能的在线键盘测试
PLoS One. 2014 Apr 29;9(4):e96260. doi: 10.1371/journal.pone.0096260. eCollection 2014.
8
PREDICT-PD: identifying risk of Parkinson's disease in the community: methods and baseline results.PREDICT-PD:在社区中识别帕金森病的风险:方法和基线结果。
J Neurol Neurosurg Psychiatry. 2014 Jan;85(1):31-7. doi: 10.1136/jnnp-2013-305420. Epub 2013 Jul 4.
9
Value of semiquantitative analysis for clinical reporting of 123I-2-β-carbomethoxy-3β-(4-iodophenyl)-N-(3-fluoropropyl)nortropane SPECT studies.123I-2-β- 羧甲氧基-3β-(4- 碘苯基)-N-(3- 氟丙基)去甲托品 SPECT 研究的临床报告的半定量分析价值。
J Nucl Med. 2013 May;54(5):714-22. doi: 10.2967/jnumed.112.110106. Epub 2013 Mar 14.
10
Meta-analysis of early nonmotor features and risk factors for Parkinson disease.帕金森病早期非运动特征及危险因素的荟萃分析。
Ann Neurol. 2012 Dec;72(6):893-901. doi: 10.1002/ana.23687. Epub 2012 Oct 15.